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A 49-year-old prior healthy male without any cardiovas-
cular risk factors living in the western part of Switzerland, 
noted in mid of March 2020 anosmia and dysgeusia, simi-
lar to his wife and four people from his close family, with 
whom he had frequent contact and who were positive for 
SARS-CoV-2. Six weeks later, he presented to the hos-
pital with new-onset of dyspnea NYHA 3, general weak-
ness, intermittent epigastrical pain and nocturia without 
orthopnea nor fever. The retro-nasal SARS-CoV-2 PCR, 
6 weeks after initial anosmia and dysgeusia was nega-
tive but the antibody IgG blood test for SARS-CoV-2 was 
positive. Computed tomography of the lungs showed no 
pulmonary embolism, no infiltrates but left heart conges-
tion, suspected by previous thoracic X-ray (A) and pleural 
effusion (B). Echocardiography revealed diffuse hypoki-
nesia with severely depressed left- and right-ventricular 
function. The patient showed elevated C-reactive protein, 
troponin and NT-proBNP. ECG showed dynamic T-wave 
changes (C) and after ruling out coronary artery disease, 
he was diagnosed with isolated peri-myocarditis using mul-
tiparametric cardiac magnetic resonance imaging (CMR). 
CMR showed diffuse thickening of the myocardium and 
pericardium due to edema confirmed with T2 weighted 
imaging and T2 mapping (D). Further, pericardial effusion 
could be seen and tissue characterization revealed diffuse 
LGE, elevated T1 mapping values and an elevated extra-
cellular volume fraction of 38% (normal value: < 30%), 
indicating diffuse fibrosis (E). Global myocardial strain of 
all heart chambers was diffusely impaired (i.e. peak global 
longitudinal RV-strain of − 11.6% and LV-strain of − 8.7; 
normal LV-strain value: < − 15%) (F). No other cause was 
found as an underlying reason for the peri-myocarditis. In 
the clinical setting of suspected Covid-19 with respira-
tory symptoms and negative pulmonary imaging, elevated 
C-reactive protein and troponin should lead to the sus-
picion of isolated peri-myocarditis. CMR is the primary 
noninvasive imaging tool to assess peri-myocarditis, also 
in Covid-19 patients [1, 2].
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